Sorrento Therapeutics, Inc.
Symbol: SRNE
NASDAQ
0.014
USDMarktpreis heute
-0.0174
P/E-Verhältnis
-0.0016
PEG-Verhältnis
7.72M
MRK Kapital
- 0.00%
DIV Rendite
Sorrento Therapeutics, Inc. (SRNE) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 50 | 126.9 | 56.5 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 26.3 | 90.2 | 0 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 24.5 | 18.7 | 15.5 | ||||||||||||||||||||
balance-sheet.row.inventory | 0 | 10 | 8.1 | 1.8 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 3.1 | 7.5 | 3.7 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 96.4 | 173 | 86.2 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 138.4 | 126.5 | 73.9 | ||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 80.3 | 79.5 | 43.6 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 136.9 | 259.7 | 73.7 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 217.2 | 339.2 | 117.2 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 17.2 | 51.3 | 256.4 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 3.7 | 4.8 | 2 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 376.5 | 521.8 | 449.6 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 472.8 | 694.8 | 535.8 | ||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 47.5 | 27.4 | 24.7 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 30.2 | 43.5 | 26.8 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 104.3 | 194.1 | 142.6 | ||||||||||||||||||||
Deferred Revenue Non Current | 0 | 7.1 | 118.9 | 113.2 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 249.6 | 67.4 | 40.5 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 166.6 | 477.2 | 298.6 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 99.1 | 95 | 53.9 | ||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 494.5 | 616.7 | 395.1 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -1959.4 | -1386.6 | -958.3 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1.5 | 1 | 0.5 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1939.3 | 1464.3 | 1122.9 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | -18.6 | 78.7 | 165.2 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 472.8 | 694.8 | 535.8 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | -3.1 | -0.6 | -24.4 | ||||||||||||||||||||
balance-sheet.row.total-equity | 0 | -21.7 | 78.1 | 140.7 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||||
Total Investments | 0 | 43.5 | 141.5 | 256.4 | ||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 134.5 | 237.6 | 169.4 | ||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 110.9 | 200.9 | 112.9 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -577.8 | -429.1 | -314.4 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 13.2 | 12.5 | 11 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -1.8 | -35.9 | -2.1 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 74.8 | 90.2 | 31.4 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 69.6 | -2.8 | 3.8 | ||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -5.7 | -3 | -1.1 | ||||||||||||||||||||
cash-flows.row.inventory | 0 | -9.5 | 8.6 | 10.2 | ||||||||||||||||||||
cash-flows.row.account-payables | 0 | 9.9 | -3.9 | -3.7 | ||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 74.9 | -4.6 | -1.7 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 128.1 | 83.4 | 110.8 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -13.7 | -8.9 | -37.6 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -14.9 | -36 | -2.3 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 124.8 | 0 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -28.5 | 79.8 | -39.9 | ||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -188.3 | -85.7 | -205.6 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 402.3 | 201.8 | 317.9 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | -55 | ||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 97.7 | 65.2 | 116.9 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 311.7 | 181.3 | 174.2 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -2.4 | 0.8 | 0.9 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -13 | -19.8 | -24.3 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 23.6 | 36.7 | 56.5 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 36.7 | 56.5 | 80.8 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -293.9 | -281.8 | -159.5 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -13.7 | -8.9 | -37.6 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -307.5 | -290.7 | -197.1 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 62.8 | 52.9 | 40 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 33.5 | 13 | 9.9 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 29.4 | 39.9 | 30 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 4.3 | 4.1 | 4.1 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 407.9 | 407.9 | 231.6 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 441.3 | 420.9 | 241.5 | ||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 8.6 | 10.2 | 20.2 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -183.2 | -94.5 | -109.1 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 4.3 | 4.1 | 4.1 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -183.2 | -94.5 | -109.1 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 8.6 | 10.2 | 20.2 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 14 | -15.4 | 9.7 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | 0 | -378.5 | -368 | -201.5 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -561.7 | -462.5 | -310.6 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -2.4 | -33.5 | -2 | ||||||||||||||||||||
income-statement-row.row.net-income | 0 | -559.3 | -429 | -308.6 |
Häufig gestellte Frage
Wie hoch ist die Sorrento Therapeutics, Inc. (SRNE) Gesamtvermögen?
Sorrento Therapeutics, Inc. (SRNE) Gesamtvermögen ist 472840000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.416.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -0.323.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -9.463.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -5.619.
Was ist der Sorrento Therapeutics, Inc. (SRNE) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -559331000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 134504000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 407888000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.